Samsung Biologics eyes early May RFP for 2016 listing
Samsung Biologics Co will send out a request for proposals next week for its 2016 IPO, expected to fetch over W3tr ($2.6bn), a source close to the situation told GlobalCapital Asia.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: